Selvita Appoints Piotr Prelich as a Vice President of Sales and Marketing
Selvita announced the appointment of Mr. Piotr Prelich to the position of Vice President of Sales and Marketing. Mr. Prelich will be responsible for the further establishment of Selvita’s brand in the pharmaceutical preclinical outsourcing market, both in Poland and abroad, as well as for the sales of services offered by Selvita and its subsidiary BioCentrum.
Mr. Piotr Prelich worked from 2007 to 2010 at Invitrogen (Life Technologies group) in the United Kingdom, as Director of Sales and Marketing of the HLA product line (transplantation and diagnostics), for the EMEA region. His previous professional experience includes sales positions in pharmaceutical companies such as Sanofi-Winthrop, Chinoin, Novo Nordisk, Roche Diagnostics and Abbott in Poland and Austria. In 1999-2007 he served as the CEO of Hark Company, specializing in laboratory equipment. He graduated from the Faculty of Medicine, from the Medical University of Lodz.
Topics
Organizations
Other news from the department people
These products might interest you

tritec® Chromatographic refrigerators by tritec für Labortechnik und Umweltsimulation
Energy-efficient chromatography refrigerators for precise temperature control
Safe storage of your HPLC systems at -5 °C to 20 °C with modern touchscreen display

SmartCheck by Mettler-Toledo
Check Pipette Dosing Accuracy - Lightning Fast in Under a Minute
Detect dosing errors before it gets expensive

BIOS ANALYTIQUE - Soluciones de Renting y Leasing para laboratorios by Bios Analytique
Specialists in the rental and leasing of scientific equipment for laboratories throughout Europe
Whether you have an unexpected requirement or limited budget, we have the perfect solution for you

Starlab Minizentrifuge by STARLAB
The Starlab Minicentrifuge - ahead of the curve
This compact unit delivers quiet, intuitive and smooth operation along with a modern design

KNAUER IJM NanoScaler by KNAUER
Efficient formulation of lipid nanoparticles for RNA-based therapies
Optimise drug encapsulation from 1 ml to hundreds of millilitres with minimal drug input

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
See the theme worlds for related content
Last viewed contents

Evotec to collaborate with Ology Bioservices on antibodies against Coronavirus - Antibodies were generated from convalescing COVID-19 patients
European Regulatory Committee Recommends Orphan Drug Status for GPC Biotech's Anticancer Monoclonal Antibody

More efficient biosolar cells modelled on nature - By combining light-collecting and photosynthesis proteins of different types, more energy can be produced

Artificial enzymes convert solar energy into hydrogen gas
A vaccine alternative protects mice against malaria - Vectored immunoprophylaxis injection triggers creation of antibodies that prevent malaria in 70 percent of mice

KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform - AstriVax to develop novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection

Occludin protein plays key role in spread of coronavirus throughout body’s cells - Finding gives insight into how the virus spreads throughout the human body, may help development of antiviral drugs
Merck strengthens biorefineries of the future

More Brain Lesions in Senior Women than in Men of the Same Age - The Extent of Abnormalities in the Brain’s White Matter Grows Significantly After Menopause

Gene found to be crucial for formation of certain brain circuitry - Identified using new technique that can speed identification of genes, drug candidates
Affibody and Agilent Technologies to Develop Robust Protein Sample
